ArticleGynecologic oncology reports2021

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report.

Angela L Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.